Pot’s Peak Potential
Just how big could the marijuana industry become? Possibly bigger than even the most optimistic analyst estimates to date – and these three stocks could… Read More »Pot’s Peak Potential
Just how big could the marijuana industry become? Possibly bigger than even the most optimistic analyst estimates to date – and these three stocks could… Read More »Pot’s Peak Potential
Even the issues surrounding its 737 MAX aircraft could not keep Boeing down: the company’s stock – as well as aerospace and defense stocks in… Read More »A&D Stocks (Even Boeing!) Are Outrunning The Market
Most of the presidential contenders from one of the country’s two main political parties support Medicare for All – and while several Wall Street analysts… Read More »Are Healthcare Stocks Contraindicated?
With trade tensions between the U.S. and China appearing poised to cool down, Chinese stocks – and China exchange-traded funds – have been leaders among… Read More »An ETF For China’s Rise
When it comes to dedicated marijuana ETFs, U.S. investors have only had one option available – until now. Here’s the buzz on the new cannabis… Read More »The Buzz On The New Marijuana ETF
Talk of “Medicare For All” and other dramatic changes to the American health care system from 2020 presidential contenders has not been healthy for health… Read More »Significant Upside At A Healthy Discount
Among the best-performing environmental, social and governance (ESG) oriented ETFs so far this year are a fund focused on Chinese stocks that are not state-owned… Read More »Best For Vets (And Other Top-Performing ESG ETFs)
Investors and corporations are willing to pay a high price for stakes in cannabis companies that currently generate little revenue (and whose product remains illegal… Read More »How To Value The “Pot Pioneers”
Mergers and acquisitions. Positive pipeline-related advancements. The integration of artificial intelligence. These are some of the key trends currently favoring the biotechnology sector – and… Read More »ETFs To Play Biotech’s Favorable Prognosis
A second-quarter repeat of the first-quarter rally? Unlikely. But stocks still remain the favored asset class – as long as investors are selective in their… Read More »3 Ideas 4 Q2